|
The who: • Caring • Kind • Philanthropic • Friendly • Family oriented • Fresh • Articulate • Etiquette • Tidy • Imaginative • Creative • Open • Authentic • Optimistic • Integrity • Professional • Hard working • Just do it! • Industry standard |
|
The how: • Patient centered • Outcome oriented • Easy to understand • Team approach • Affordable • Accessible • Ubiquitous • Streamlined workflow |
Competitive analysis: • Angel.co • Startuphealth • Bplan • Entrepreneur.com • Doctorpreneur • Yourstory • Informationweek • CIO |
Pharmaceuticals and biotechnology: Differentiation is development of novel Tx (collaboration with research sector), manufacturing process
• CSL CSL Limited - Senior management $46bn - Makes vaccines, antivenoms, drugs, immunoglobulins, wound healing
• SRX Sirtex Medical Limited - Senior management $2.2bn - Makes a radioactive bead treatment for inoperable liver cancer
• MSB Mesoblast Limited - Senior management $661m - Administration of cells to treat immunologic/inflammatory, cardio/vascular, orthopedic/back pain, oncology
• VRT Virtus Health Limited - Senior management $516m - Assisted reproductive services for infertility
• MYX Mayne Pharma Group Limited - Senior management $1.1bn - Special drug delivery (delayed release, sustained release, bioavailable) for drugs
Health care provider: Differentiation is superior customer service, patient outcomes, speed and efficiency, affordability, availability, accessibility
• RHC Ramsay Health Care Limited - Senior management $13bn - Owns private hospitals throughout Australia
• SHL Sonic Healthcare Limited - Senior management $8.3bn - Provides lab pathology and radiology services
• HSO Healthscope Limited - Senior management $4.3bn - Owns private hospitals, medical centers, psychiatric clinics, rehab clinics, pathology services
• EHE Estia Health Limited - Senior management $1.3bn - Aged care facilities
• REG Regis Healthcare Limited - Senior management $1.7bn - Private aged care residence
• PRY Primary Health Care Limited - Senior management $1.6bn - Operates medical centers, pathology labs, diagnostic imaging, practice management software, health insurance fund
• SIP Sigma Pharmaceuticals Limited - Senior management $854m - Wholesale and distribution to pharmacies
• JHC Japara Healthcare Limited - Senior management $805m - Aged care, retirement living, independent living (Dementia, Alzheimer, respite)
• GXL Greencross Limited - Senior management $584m - Pharmacies, family medical centers, community care
Medical equipment and supplies: Differentiation is novel inventions
• RMD Resmed Inc - Senior management $11bn - Makes products that help Dx and Tx sleep disorders, COPD, or other respiratory diseases, including masks, machines
• COH Cochlear Limited - Senior management $5.3bn - Makes cochlear, acoustic and bone conduction implants
• FPH Fisher & Paykel Healthcare Corporation Limited - Senior management $4.3bn - Makes products for respiratory care and OSA
• ANN Ansell Limited - Senior management $3.3bn - Makes medical gloves and condoms
Non-ASX 200:
• STW SPDR S&P/ASX 200 fund $3.1bn
• EBO EBOS Group Limited - Senior management $2bn - Pharmaceutical wholesale distribution, wholesaler, third party logistics
• API Australian Pharmaceutical Industries Limited - Senior management $998m - Pharmaceutical manufacturing, distribution, and retailing
• SNZ Summerset Group Holdings Limited - Senior management $798m - Developer and operator of retirement villages
• VLA Viralytics Limited - Senior management $516m - Viruses that preferentially infect and kill cancer cells
• OHE Orion Health Group Limited - Senior management $493m - Makes health software that helps with storing and interpreting data, communication, integration, safety and efficiency
• NAN Nanosonics Limited - Senior management $458m - Disinfectant containing a mist that helps with infection control
• MVP Medical Developments International Limited - Senior management $402m - Make spacer chambers for asthma/COPD, medical devices, veterinary devices
• MVF Monash IVF Group Limited - Senior management $357m - IVF treatment for infertility
• PSQ Pacific Smiles Group Limited - Senior management $327m - Dental care centers
• RVA Reva Medical, Inc - Senior management $316m - Develops minimally invasive medical devices, in interventional cardiology, including a drug eluting bioresorbable coronary scaffold for treating coronary artery disease
• IPD Impedimed Limited - Senior management $302m - Medical devices that use bioimpedence technology, applying a mild electrical current to the body. This can measure fat mass, and fluid levels, and therefore body composition and lymphedema
• PME Pro Medicus Limited - Senior management $286m - Makes practice management software, medical imaging software, mobile software, external access to images and reports
• IDX Integral Diagnostics Limited - Senior management $258m - On and off-site radiologist, allowing doctors to access images at any time from any location
• SPL Starpharma Holdings Limited - Senior management $250m - Synthetic nano polymer with antimicrobial properties, used to deliver drugs, and agrochemicals
• BNO Bionomics Limited - Senior management $212m - Synthetic methods to make drugs, to treat cancer, CNS disorders (e.g. anxiety, depression, Alzheimer's)
• VEI Vision Eye Institute Limited - Senior management $192m - Ophthalmic consulting facilities (surgeries, refractive and laser eye surgery)
• TPE TPI Enterprises Limited - Senior management $190m - Licensed poppy processor, producing narcotic raw material for the pharmaceutical industry
• AXP Airxpanders, Inc. - Senior management $186m - Controlled tissue expander for patients undergoing breast reconstruction following a mastectomy
• ONT 1300 Smiles Limited - Senior management $181m - Dental facilities in major population centers
• NEU Neuren Pharmaceuticals Limited - Senior management $154m - Develop treatments for brain injury, neurodevelopmental and neurodegenerative disorders, which have no drugs approved currently
• CAJ Capitol Health Limited - Senior management $154m - Bulk billing diagnostic imaging services
• AHZ Admedus Ltd - Senior management $142m - Research into vaccine technology targeting HSV2 and HPV, commercialising cardiovascular patch, sales and distribution of own and others' medical devices and consumables
• SOM Somnomed Limited - Senior management $142m - Dx and Tx of sleep related disorders, including continuous open airway therapy
• TTC Traditional Therapy Clinics Limited - Senior management $141m - Franchiser and owner of traditional therapeutic heath and wellness clinics
• LHC Lifehealthcare Group Limited - Senior management $136m - Supplier of medical devices, including spine, orthopedics, neurophysiology, surgical instrumets and consumables, bariatric, capital equipment, utlrasound, biologics, vascular
• CUV Clinuvel Pharmaceuticals Limited - Senior management $134m - Developing drugs for severe skin disorders
• ACR Acrux Limited - Senior management $114m - Commercializing topical products using proprietary drug delivery technology, a patch involving fast-drying and invisible topical application
• PRR Prima Biomed Ltd - Senior management $113m - Cancer immunotherapy, cancer vaccine, monoclonal antibody
• WDE Wealth Defender Equities Limited - Senior management $107m
• PGC Paragon Care Limited - Senior management $105m - Provider of healthcare equipment and consumables, sales, and servicing/maintenance
• OBJ Obj Limited - Senior management $104m - Magnetic, micro-array drug delivery technologies, including transdermal, dermatological, cosmetic, oral health strips, mouth guards
• PXS Pharmaxis Ltd - Senior management $81m - Makes respiratory products (dry powder for Tx of cystic fibrosis, and LFT to help Dx asthma), and researching Tx for inflammatory and fibrotic diseases
• PHG Pulse Health Limited - Senior management $80m - Specialist rehabilitation hospitals and units providing outpatient/day therapy programs
• IDT IDT Australia Limited - Senior management $79m - Manufacture of beta lactams, micrbiological and analytical testing, clinical packaging
• UBI Universal Biosensors Inc. - Senior management $79m - Research and manufacture of Dx systems for professional and home use, including blood cooagulation analyzer for patients taking warfarin, blood glucose monitor, and other application of its electrochemical sensor
• CMP Compumedics Limited - Senior management $75m - Develop and manufacture diagnostics technology for sleep, brain and ultrasonic blood-flow monitoring
• SDI SDI Limited - Senior management $74m - Dental products, including alloys, adhesives, composites, tooth whitening, sealants, cements, equipment
• ELX Ellex Medical Lasers Limited - Senior management $73m - Design, manufacture and market lasers used by phthalmologists, including photodisrupters, photocoagulators, laser trabeculoplasty for Tx cataract, retina and glaucoma conditions
• PNV Polynovo Limited - Senior management $72m - Biodegradeable material providing temporary tissue support and cellular scaffolding. Constructed to degrade by hydrolysis in a non-toxic way, metabolized or cleared from the body
• ADR Adherium Limited - Senior management $69m - Wireless communications technology to provide real time data collection and reporting from inhalers, used for patients with chornic respiratory disease
• ADO Anteo Diagnostics Limited - Senior management $67m - Develop and commercializes nanoglue technology, used by healthcare customers, to enable lab test results to be delivered faster, cheaper, or greater specificity
• CLV Clover Corporation Limited - Senior management $64m - Improves health with omega 3 fatty acids, integrating it into infant nutrition, medical foods markets
• VSC Vita Life Sciences Limited. - Senior management $64m - Makes and sells supplements, vitamins, minerals, meal replacement, sports nutrition, herbals
• PBT Prana Biotechnology Limited - Senior management $61m - Tx neurodegenerative disease, including Alzheimer's and Huntington's, using metal protein attenuating compounds
• OSL Oncosil Medical Ltd - Senior management $58m - Medical device that makes localized stream of beta radiation, made by melting 5% phosphorus in liquid silicon. The particles can be emitted for up to 3 months. It is used for IV chemotherapy, and external beam radiation
• NRT Novogen Limited - Senior management $54m - 3D printing technology to assemble living tissue cells into a desired pattern, combined with ECM to make complex structures, e.g. organs
• AVH Avita Medical Ltd - Senior management $52m - Developing and marketing respiratory and regenerative products, including spray on skin for Tx of burns, and inhalers
• CIR Circadian Technologies Limited - Senior management $51m - Drug developer for ophthalmic disease, using VEGF, which blocks blood and lymphatic vessel growth and inhibits vascular leakage
• UNS Unilife Corporation - Senior management $50m - Manufacture and supplier of injectible drug delivery system, to inject biologics, drugs and vaccines
• GTG Genetic Technologies Limited - Senior management $50m - Molecular testing for genetic tests, including molecular tests for cancer development, progression and management
• BLT Benitec Biopharma Limited - Senior management $45m - Develops gene-silencing therapies to Tx chronic and life-threatening diseases using DNA-directed RNA interference
• AIK Armidale Investment Corporation Limited $44m
• GSS Genetic Signatures Limited - Senior management $44m - Develop and commercialize real time PCR based products for routine detection of infectious diseases, to screen for various infectious pathogens with high specificity quickly
• CGS Cogstate Ltd - Senior management $41m - Commercializes rapid, reliable, and sensitive computeried cognitive tets for clinical trials, academic research, healthcare, and brain injury
• DVL Dorsavi Ltd - Senior management $37m - Wearable wireless sensor technology, which measures and analyzes the way we move. It includes a muscle and movement sensor. It uses accelerometers, magnetometers and gyroscopes
• ACG Atcor Medical Holdings Limited - Senior management $37m - Quick and non-invasive measurement of central blood pressure and arterial stiffness, using a cuff based device
• ANR Anatara Lifesciences Ltd - Senior management $35m - Non-antibiotic oral solution for GI diseases in animals and humans. It helps address concerns of overuse ofa ntibiotics in animals, causing antibiotic resistance
• IIL Innate Immunotherapeutics Limited - Senior management $35m - Designs and manufactures an immunomodulator microparticle technology, used to induce the human immune system to fight certain cancers and infections, or modulated imune mechanisms implicated in autoimmune diseases e.g. MS. It uses a unique delivery system, which attaches to selected modulators to the microparticle, namely, immunostimulatory ligands or triggers
• IMC Immuron Limited - Senior management $35m - Oral immunotherapy utilizing polyclonal antibodies that target the GI immune system and gut microbiome. This is used to Tx various immune mediated and inflammatory disorders, including colitis, arthritis, inflammatory bowel disease
• CYC Cyclopharm Limited - Senior management $34m - Provides radiopharmaceutical products used in nuclear medicine departments
• MMJ MMJ Phytotech Limited - Senior management $33m - Develop and commercializes canabinoid based Tx products, and grows and supplies unique strains of cannibus in newly regulated markets
• ACL Alchemia Limited - Senior management $31m - Drug research, including late stage oncology product, antithrombotic, anticancer compounds
• AJJ Asian American Medical Group Limited - Senior management $30m - Liver center, providing transplantation service, radiation oncology program
• ACW Actinogen Medical Limited - Senior management $28m - Developing novel drug to Tx of Alzheimer's disease and mild cognitive impairment, by blocking the development of cotisol which appears to contribute to cognitive impairment and neurological plaques
• CYP Cynata Therapeutics Limited - Senior management $27m - Therapeutic stem cell and regenerative medicine company, used to isolate human embryonic stem cells, derive induced pluripotent stem cells
• 3DM 3D Medical Limited - Senior management $26m - 3D printing of anatomical parts and functions, sharing medica limaging data, virtual reality imaging techniques allowing you to manipulate/crop/dissect a suspended image, manipulate images using hand movements alone, translate existing big data into more meaningful format
• GBI Genera Biosystems Limited - Senior management $25m - Develops and ocmmercializes molecular diagnostic test, to provide relevant molecular Dx assays
• BRC Brain Resource Limited - Senior management $24m - Evidence based brain health assessment, exercises that target both cognition and emotions
• CDY Cellmid Limited - Senior management $24m - Novel Dx and Tx for numerous cancer indications, particularly solid tumors, using novel oncology target midkine and midkine antagonists globally
• MEB Medibio Limited - Senior management $24m - Validation and commercialization of cicardian heart rate variability technology
• LCT Living Cell Technologies Limited - Senior management $21m - Develop and commercialize regenerative Tx which restore function using naturally occurring cells, namely alginate coated capsule containing clusters of neonatal porcine choroid plexus cells, which may help Parkinson's, Huntington's, Alzheimer's, and motor neurone disease
• KKT Konekt Limited - Senior management $20m - Organizational health and risk management solutions, examining procedures and cultures
• PBP Probiotec Limited - Senior management $20m - Manufacture, marketer and distributor of various prescription and OTC drugs, complementary drugs, and specialty ingredients
• AZV Azure Healthcare Limited - Senior management $19m - Nurse call system and clinical work flow solution
• ICS Icsglobal Limited - Senior management $19m - Medical billing and colcetions providing taiored billing services for bosses and specialists
• BIT Biotron Limited - Senior management $17m - Develop novel small molecule antiviral Tx targetting hepatitis C and HIV, using a drug which targets a new class of viral proteins identified
• LBT LBT Innovations Limited - Senior management $17m - Automated solutions to prepare and analyze microbiology culture specimens, useful for busy clinical labs. It uses an automated culture-plate streaking system, as well as automated reading of culture plates after incubation
• MDC Medlab Clinical Limited - Senior management $17m - Pathology service provided to GP, specialist, medical center, nursing homes
• CTE Cryosite Limited - Senior management $13m - Cord blood and tissue banking, including stem cell resarch and development section
• GID GI Dynamics, Inc - Senior management $13m - Endoscopically delivered device Tx to mimic mechanisms of metabolic surgery, wihtout altering the anatomy. It is used to Tx diabetes and obesity populations
• ANP Antisense Therapeutics Limited - Senior management $12m - Drug discovery and development to create, develop and commercialize novel antisense Tx, due to discovery of many new disease-causing proteins
• PGL Progen Pharmaceuticals Limited - Senior management $12m - Novel oncology solutions to Tx cancer, using anti-angiogenesis and anti-metasttatic compounds, blocking signalling of multiple growth factors including FGF-1, FGF-2, VEGF
• TIS Tissue Therapies Limited - Senior management $12m - Develops and manufactures synthetic proteins for wound healing application. Used to Tx venous leg ulcers and diabetic foot ulcers
• BTC Biotech Capital Limited - Senior management $11m - Pooled development fund assessing new investment opportunities
• PAR Paradigm Biopharmaceuticals Limited - Senior management $10m - Repurposing (i.e. new indications for old drugs) the drug pentosan polysulphate sodium for lead clinical indication of bone marrow edema, and to Tx respiratory disease (allergic asthma,a llergic rhinitis, COPD)
• FFC Farmaforce Limited - Senior management $8.8m - Provide pharmaceutical companie with contract sales service to GP's, specialist, pharmacist
• RHS Reproductive Health Science Limited - Senior management $8.3m - Develop advanced single cell genomic technologies
• DXB Dimerix Limited - Senior management $8m - Drug discovery and development, repurposing existing molecules. Has technology which finds receptor interactions, e.g. to G-protein coupled receptors
• GLH Global Health Limited - Senior management $8m - Develpers of software applications for healthcare, including to enhance connectivity, EMR, data warehousing, practice management software, patient software
• PTX Prescient Therapeutics Limited - Senior management $7.7m - Novel compoundsto Tx various cancers, that are resistant to front line chemo, including in cancers of the breast, ovary, leukemia, and multiple myeloma
• PAA Pharmaust Limited - Senior management $7.5m - Develop drugs, including to Tx various cancers, often in terminal cancers
• MLA Medical Australia Limited - Senior management $7.4m - Manufacture and distirbute various medical devices and consumables, including burettes, extension sets, IV sets, irrigation sets, transfusion sets, and hand pump sets
• OIL Optiscan Imaging Limited - Senior management $7.3m - Microscopic/minitarized imaging technology, including confocal microscope
• IVX Invion Limited - Senior management $7.2m - Drug development for Tx of inflammatory diseaess including asthma,c hronic bronchitis, and lupus
• MDG Medtech Global Limited - Senior management $7m - Software developer, including for treatment, electronic health records, patient end, data intelligence, data mobility, SMS technology
• PIQ Proteomics International Laboratories Ltd - Senior management $7m - Dx, Tx, and analytics, using biomarkers for diabetic kidney disease
• ALT Analytica Limited - Senior management $6.5m - e-health Tx for stress urinary incontinence, using a device, web portal and smartphone app, to evaluate activity of pelvic floor muscles
• PAB Patrys Limited - Senior management $6.3m - Develop product to Tx cancer, using natural human antibodies
• BXN Bioxyne Limited - Senior management $4.6m - Consumer dietary supplements and probiotics, used to help w/ immune health and immunotherapeutics
• VAN Vango Mining Limited - Senior management $3.9m
• SCU Stemcell United Limited - Senior management $2.9m
• AGX Agenix Limited - Senior management $2m - Monoclonal antibody Dx
• BPH BPH Energy Ltd - Senior management $1.9m - Provides product development and commercial direction, including a portfolio of, a method of detecting infectious disease, measurement of EEG to see response to drugs adminsitered during surgery, molecular marker for cancer detection, and drugs that target tumor vasculature
• MGZ Medigard Limited - Senior management $1.8m - Design and development of retractable safety devices, including syringe, blood collection, IV valve, flash back needle
• BNE Bone Medical Limited - Senior management $1.5m - Drugs for bonoe and joint disease, includigng Tx for osteoporosis and arthritis, including exploration of oral calcitonin and parathyroid hormone for Tx bone disease
• IMI IM Medical Ltd - Senior management $1.2m - Underoging redevelopment to find a new future direction
• SIE Scigen Limited - Senior management $1m - Develop, manufacture and market recombinatn human derived products, focusing in areas of endocrinology, gastro, and imunology. Products include rhuman growth hormone, rhuman insulin and rhuman GCSF
• TDX Tyrian Diagnostics Limited - Senior management $1m - Rapid diagnosis technology, used to determine wheat quality, using a small disposable plastic capsule, and USB driven reader machien to assess results precisely. It also has proprietary markers for Dx of active tuberculosis
• AMT Allegra Orthopaedics Limited $0
• AVX Avexa Limited $0
• FIT Fitgenes Limited $0
• FXP Currency Warrant AUD/GBP $0
• FXU Currency Warrant AUS/USD. $0
• FXZ Currency Warrant AUS/NZD $0
• IM1 I M Quarries Limited $0
• MDV Medivac Limited $0
• MEQ Metlifecare Limited $0
• MMT NSX - Mount Rommel Mining Limited $0
• NMG Noble Mineral Resources Limited $0
• PAW Pawnee Energy Limited $0
• PNA PanAust Limited $0
• PNO Pharmanet Group Limited $0
• QRX QRXPharma Ltd $0
• SLA Solagran Limited $0
• STI Stirling Products Limited $0
• TEO Telesso Technologies Limited $0
• TOL Toll Holdings Limited $0
• WDC Westfield Group $0
• ZCL Light, Sweet Crude Oil Futures (NYMEX) $0
• ZGC Comex Gold Futures (CME) $0
• ZSI Comex Silver Futures (CME) $0